-+ 0.00%
-+ 0.00%
-+ 0.00%
Gary Roubin Spends US$100k Buying InspireMD Shares
Share
Listen to the news

Whilst it may not be a huge deal, we thought it was good to see that Gary Roubin, who is a company insider, recently bought US$100k worth of stock, for US$0.65 per share. While we're hesitant to get too excited about a purchase of that size, we do note it increased their holding by a solid 18%.

The Last 12 Months Of Insider Transactions At InspireMD

In the last twelve months, the biggest single sale by an insider was when the insider, Shane Gleason, sold US$190k worth of shares at a price of US$3.65 per share. While insider selling is a negative, to us, it is more negative if the shares are sold at a lower price. The silver lining is that this sell-down took place above the latest price (US$0.69). So it may not tell us anything about how insiders feel about the current share price. Shane Gleason was the only individual insider to sell over the last year.

Happily, we note that in the last year insiders paid US$654k for 728.99k shares. But insiders sold 146.49k shares worth US$289k. Overall, InspireMD insiders were net buyers during the last year. Their average price was about US$0.90. These transactions suggest that insiders have considered the current price attractive. The chart below shows insider transactions (by companies and individuals) over the last year. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

See our latest analysis for InspireMD

insider-trading-volume
NasdaqCM:NSPR Insider Trading Volume November 19th 2026

InspireMD is not the only stock insiders are buying. So take a peek at this free list of under-the-radar companies with insider buying.

Insider Ownership

Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Our data indicates that InspireMD insiders own about US$3.2m worth of shares (which is 11% of the company). We do generally prefer see higher levels of insider ownership.

So What Does This Data Suggest About InspireMD Insiders?

It is good to see recent purchasing. We also take confidence from the longer term picture of insider transactions. However, we note that the company didn't make a profit over the last twelve months, which makes us cautious. On this analysis the only slight negative we see is the fairly low (overall) insider ownership; their transactions suggest that they are quite positive on InspireMD stock. While it's good to be aware of what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. For instance, we've identified 3 warning signs for InspireMD (2 are potentially serious) you should be aware of.

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending